Astrazeneca PLC (NYSE:AZN) Reported Basic Consolidated EPS Of $2.2358 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Astrazeneca PLC (NYSE:AZN) for the period ended 2015-12-31 was $2.2358. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $2.2358.

EPS from continuing operations

Coming to basic EPS from continuing operations, Astrazeneca PLC (NYSE:AZN) reported $2.2358 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $2.2358.

EPS contribution from parent

For the annual period ended 2015-12-31, Astrazeneca PLC (NYSE:AZN) received basic EPS of $2.235 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $2.235.

Basic net EPS

For the annual period ended 2015-12-31, Astrazeneca PLC (NYSE:AZN) reported basic net EPS of $2.23. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $2.23.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $2.234. For the quarter ended 2015-12-31, consolidated diluted EPS was $2.234.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $2.234 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $2.234.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $2.23. For the quarterly period ended 2015-12-31, net diluted EPS was $2.23.

Diluted EPS from parent

From the parent company, Astrazeneca PLC (NYSE:AZN) received diluted EPS of $2.2332 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $2.2332.

Astrazeneca PLC (NYSE:AZN) posted net basic EPS reading of $2.23 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $2.23 was for the quarter ended 2015-12-31.

Net diluted EPS for Astrazeneca PLC (NYSE:AZN) for the annual period ended 2015-12-31 was $2.23. The company also reported net diluted EPS reading of $2.23 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 1264 while for the quarter ended 2015-12-31 is 1264.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 1264 while for the quarter ended 2015-12-31 is 1264.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 22 times, 1 visits today)